Sunday, November 8, 2026 · Seoul

AboutStandardsRSS

Seoul Market Wire

Korean stocks, the won and the economy

  • KOSPI5,059.69-6.02%
  • KOSDAQ644.27-5.03%
  • USD/KRW1,364.0+0.52%
  • Samsung Elec.188,700-6.35%
  • SK hynix1,132,000-10.44%

KRX close & FX ref. 2026-11-06 (KST)

KOSDAQ · 214450.KQ · 파마리서치

PharmaResearch

234,500 won+4.22%KRX close 2026-11-06

One year, weekly closes

52-week high
561,000
52-week low
208,000
Year to date
-41.8%

Broker consensus

491,250 won average target

8 brokerages · median 485,000 · range 420,000–600,000 · average target +109.5% vs last close

Ratings: Buy 8

Latest target from each brokerage in the past 180 days. Targets and ratings are the brokerages' own; Seoul Market Wire publishes none.

Price-target history
DateBrokerageRatingTarget (won)PreviousChangeReport
2026-10-29Kyobo SecuritiesBuy530,000530,0000.0%Korean
2026-10-29Daishin SecuritiesBuy460,000620,000-25.8%Korean
2026-10-29Eugene Investment & SecuritiesBuy420,000——Korean
2026-10-28Kiwoom SecuritiesBuy430,000520,000-17.3%Korean
2026-08-18Mirae Asset SecuritiesBuy600,000——Korean
2026-08-10Kyobo SecuritiesBuy530,000530,0000.0%Korean
2026-08-10Yuanta Securities KoreaBuy450,000——Korean
2026-08-10Daishin SecuritiesBuy620,000——Korean
2026-08-10IBK SecuritiesBuy530,000——Korean
2026-08-10Shinhan SecuritiesBuy510,000430,000+18.6%Korean
2026-08-10Kiwoom SecuritiesBuy520,000510,000+2.0%Korean
2026-07-16Kyobo SecuritiesBuy530,000——Korean
2026-07-16Shinhan SecuritiesBuy430,000——Korean
2026-07-16Kiwoom SecuritiesBuy510,000——Korean

Korean brokerage reports since 2026-04-22, newest first. Change is against the same brokerage's previous target. Source: reports listed on Naver Pay Securities research. Updated 2026-11-08 03:51 KST.

Investor flows, last 20 sessions
DateForeign, sharesForeign, approx. wonInstitutions, approx. wonForeign ownership
2026-11-06-55,104−₩13.0bn+₩14.3bn16.65%
2026-11-05-14,565−₩3.3bn+₩4.7bn17.18%
2026-11-04-9,647−₩2.2bn+₩3.7bn17.59%
2026-11-03-3,803−₩0.8bn+₩0.6bn17.74%
2026-11-025,511+₩1.2bn+₩0.5bn17.60%
2026-10-3030,595+₩6.4bn−₩4.3bn17.55%
2026-10-2924,924+₩5.5bn−₩5.6bn17.21%
2026-10-2831,091+₩7.1bn−₩6.2bn17.03%
2026-10-2711,687+₩2.7bn−₩0.4bn16.71%
2026-10-2624,974+₩5.7bn−₩3.8bn16.66%
2026-10-2344,520+₩10.5bn−₩15.4bn16.38%
2026-10-2231,076+₩7.9bn−₩8.4bn16.02%
2026-10-213,101+₩0.8bn−₩2.9bn15.52%
2026-10-2048+₩0.0bn−₩1.3bn15.51%
2026-10-19-4,505−₩1.3bn+₩0.5bn15.57%
2026-10-16-6,630−₩1.8bn+₩6.4bn15.68%
2026-10-1597,605+₩24.8bn−₩4.5bn15.69%
2026-10-1417,916+₩4.8bn−₩4.5bn14.70%
2026-10-1369,605+₩19.0bn−₩24.2bn14.89%
2026-10-1220,551+₩6.1bn+₩1.9bn14.10%

Net buying (+) or selling (−) by foreign investors and institutions. Won values are shares × that day's close, so approximate. Source: Korea Exchange data via Naver Pay Securities.

Stories

No stories on PharmaResearch yet.

For information only. Not investment advice. See our disclaimer.